Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 429.87Cr 63Cr 56Cr 52Cr 48Cr 89Cr 6.15TCr 91Cr 620.04Cr 241.85Cr 3TCr 238.25Cr 233.09Cr 10TCr P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 412.99Cr 61Cr 54Cr 50Cr 46Cr 86Cr 5.9TCr 87Cr 595.69Cr 232.35Cr 2.88TCr 228.89Cr 223.94Cr 9.99TCr EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+1.85%
1 week-10.05%
Current month+0.39%
1 month-1.28%
3 months-19.20%
6 months-18.78%
Current year-3.02%
1 week 7.15
Extreme 7.15
7.94
1 month 7.08
Extreme 7.08
8.78
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
15.19
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/09/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21 Sell

Executive/Senior Manager

77,000 0.0189%
09/06/21 Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+1.85%-10.05%-13.77%+17.92% 66Cr
+0.93%+1.80%+49.02%+161.32% 1,05700Cr
+1.35%+3.88%+55.02%+53.64% 62TCr
+0.56%+1.93%+35.93%+81.16% 45TCr
+1.34%+6.28%+33.99%+29.87% 34TCr
-0.94%+1.54%+35.70%+39.78% 30TCr
+0.08%+1.11%+16.76%+18.13% 26TCr
+0.33%-1.79%-27.52%-41.09% 22TCr
+1.21%+3.11%+22.40%+60.42% 20TCr
-0.71%-2.84%+15.25%+67.99% 16TCr
Average +0.62%+0.59%+22.28%+48.91% 36.15TCr
Weighted average by Cap. +0.70%+1.57%+35.99%+78.01%

Financials

2024 2025
Net sales 98Cr 15Cr 13Cr 12Cr 11Cr 20Cr 1.41TCr 21Cr 141.87Cr 55Cr 685.86Cr 55Cr 53Cr 2.38TCr 120.53Cr 18Cr 16Cr 15Cr 13Cr 25Cr 1.72TCr 26Cr 173.85Cr 68Cr 840.48Cr 67Cr 65Cr 2.92TCr
Net income 1.37Cr 20.15L 17.73L 16.47L 15.14L 28.4L 20Cr 28.91L 1.97Cr 76.8L 9.52Cr 75.66L 74.03L 33Cr 9.27Cr 1.37Cr 1.2Cr 1.12Cr 1.03Cr 1.93Cr 132.58Cr 1.96Cr 13Cr 5.22Cr 65Cr 5.14Cr 5.03Cr 224.35Cr
Net Debt 19Cr 2.79Cr 2.46Cr 2.28Cr 2.1Cr 3.93Cr 270.33Cr 4Cr 27Cr 11Cr 131.86Cr 10Cr 10Cr 457.44Cr -17Cr -2.49Cr -2.19Cr -2.04Cr -1.87Cr -3.51Cr -241.34Cr -3.57Cr -24Cr -9.5Cr -117.72Cr -9.36Cr -9.15Cr -408.4Cr
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
24/26/24 CN¥7.390 -4.03% 1,46,78,430
23/26/23 CN¥7.700 +1.85% 1,61,90,736
22/26/22 CN¥7.560 +0.40% 1,98,04,200
21/26/21 CN¥7.530 -1.57% 2,22,40,064
20/26/20 CN¥7.650 -1.67% 2,12,99,950

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock